Searched for
INCOVACC
ET Business Reformer of the year: Mansukh Mandaviya - Building a bigger ‘Obamacare’ in IndiaMandaviya was given the critical health portfolio in July 2021 when the country was still reeling from the second Covid wave. He was promot...- 3 lakh doses of intranasal Covid vaccine sent to hospitals: Bharat Biotech's Krishna EllaHe was speaking on the sidelines of an event here at which a bilateral agreement was signed between the University of Wisconsin (UW)-Madiso...
- Incovacc, World's first nasal vaccine, in private hospitals from next week"Launch of Incovacc today is an important milestone under Atma Nirbhar Bharat efforts, Mandaviya said. "Today, 65% of vaccines for the worl...
- Bharat Biotech's nasal Covid vaccine iNCOVACC launchedThe announcement regarding the launch of iNCOVACC on January 26 was made last week by the company’s chairman and managing director. The nas...
- On January 26, India's first COVID intranasal vaccination iNCOVACC will go on saleiNCOVACC, a brand-new domestic drug, has been introduced by Bharat Biotech to aid in the fight against COVID 19. The nasal Covid vaccine ha...
- First Indian intranasal Covid vaccine to be launched on Jan 26"Our nasal vaccine will be officially launched on January 26, on Republic Day," the company's chairman and managing director Krishna Ella s...
- Govt may not procure Bharat Biotech's intranasal Covid vaccine iNNOVACCBharat Biotech has made its intranasal Covid-19 vaccine iNNOVACC available on CoWin, priced at ₹800 per dose for private markets and ₹325 f...
- A nose for wider booster vaccinationThe development of the first nasal Covid vaccine, along with others before it, is an affirmation of India's capacity to provide solutions t...
- Gennova eyes nod for omicron-specific vaxAs Covid-19 cases saw an uptick in other countries, the government in November approved Bharat Biotech's intranasal vaccine iNCOVACC for he...
- What you need to know about getting Bharat Biotech's nasal vaccine iNCOVACCBharat Biotech has recently introduced its intranasal Covid vaccine, which will be given as a booster dose, as concerns about the Covid BF....
- Bharat Biotech's intranasal vaccine Incovacc to debut on Co-WinThis is the world's first intranasal vaccine for Covid-19 to receive approval for the primary 2-dose schedule, and as a heterologous booste...
- Private hospitals in talks with Bharat Biotech for intranasal Covid-19 vaccine"We have written to Bharat Biotech, asking how we can procure the supply, about the pricing, etc," a senior executive at a private hospital...
- Covid Nasal Vaccine: Here is how to book an appointment for a booster dose on CoWINThe Union Health Ministry has approved Bharat Biotech's intranasal Covid vaccine, iNCOVACC, for use as a booster dose. The vaccine is avail...
- Covid-19: Bharat Bio's nasal vaccine iNCOVACC set to cost Rs 325 at government hospitals, Rs 800 otherwiseThe vaccine, iNCOVACC (BBV154), is available on CoWin, and priced at Rs 800 for private markets and Rs 325 for supplies to the Centre and s...
- Covid-19 nasal vaccine is here: Price, benefits, all you need to knowBharat Biotech has finally announced the price of its intra nasal vaccine for Covid-19, the first in the world. Here is the price of Bharat...
- Covid: Things to know about Bharat Biotech's nasal vaccineBharat Biotech’s intranasal Covid vaccine, iNCOVACC is set to be included in the vaccination program.
- Nasal vaccine to be available soon as booster, privately and on Cowin platformThe ministry will also start holding mock drills in hospitals across the country to assess the preparedness to address any surge in Covid c...
- Bharat Biotech’s intranasal vaccine ‘iNCOVACC’ receives CDSCO approval under restricted useThe Central Drugs Standard Control Organisation (CDSCO) gave its nod to the vaccine for use as both primary series as well as a heterologou...
- SEC to review Bharat Bio's intranasal jab for use as booster soonCovaxin - and has submitted the data to the Drugs Controller General of India (DCGI) for the review. Hyderabad based Bharat Biotech has sou...
- Bharat Biotech seeks DCGI nod for phase-3 study of intranasal Covid vaccine in 5-18 age groupiNCOVACC is a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilised spike protein. This vaccine candid...
Load More
